Jeffrey Yu
CIK 1991132 · Chief Medical Officer · last filed 2026-06-24
Jeffrey Yu is a Chief Medical Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2025. The most recent filing shows the insider bought $100.0K of ONMD on Jun 24, 2026. Across all open-market trades the lifetime net is +$1.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.52M
2
6
$1.94M
Holdings By Company
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | ONMD | Buy (P) | +158,730 | $100.0K | EDGAR |
| 2026-06-17 | ONMDW | Buy (P) | +172,414 | $100.0K | EDGAR |
| 2026-04-24 | ONMDW | Mixed | +1,123,043 | $932.1K | EDGAR |
| 2025-11-26 | ONMDW | Mixed | +240,309 | $140.5K | EDGAR |
| 2025-11-26 | ONMDW | Mixed | +4,563,028 | $2.80M | EDGAR |
| 2025-11-26 | ONMDW | Mixed | +67,762 | $17.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.